ST段抬高型心肌梗死住院患者中COVID-19诊断与院内死亡率的关联
该回顾性队列研究纳入美国509家中心2019年1月至2020年12月连续收治的80449例院外或院内STEMI成人患者,比较合并与不合并活动性COVID-19感染者的特征、治疗和结局,并按COVID-19诊断可能性进行倾向性匹配。院外STEMI组匹配后551例有COVID-19 vs 2755例无COVID-19,院内STEMI组252例有COVID-19 vs 756例无COVID-19。院外STEMI患者是否接受直接经皮冠状动脉介入治疗在COVID-19状态间无显著差异;院内STEMI合并COVID-19者接受侵入性诊断或治疗性冠状动脉操作显著更少。院内死亡率院外STEMI为15.2% vs 11.2%(绝对差4.1%[95%CI 1.1%-7.0%],P=.007),院内STEMI为78.5% vs 46.1%(绝对差32.4%[95%CI 29.0%-35.9%],P<.001)。作者认为需进一步研究理解该关联的潜在机制。
要点
- 院内STEMI合并COVID-19者院内死亡率78.5% vs 无COVID-19者46.1%(绝对差32.4%[95%CI 29.0%-35.9%],P<.001),为最高危亚组。
- 院外STEMI合并COVID-19者院内死亡率15.2% vs 无COVID-19者11.2%(绝对差4.1%[95%CI 1.1%-7.0%],P=.007)。
- 院外STEMI患者接受直接经皮冠状动脉介入治疗的可能性在COVID-19状态间无显著差异。
- 院内STEMI合并COVID-19者接受侵入性诊断或治疗性冠状动脉操作显著少于无COVID-19者。
- 合并COVID-19的院内STEMI患者院内死亡风险极高,床旁应优先识别并强化监护。
适用人群与场景
- 美国509家中心2019年1月至2020年12月连续收治的成人STEMI患者(随访截止2021年1月),包括院外STEMI 76434例和院内STEMI 4015例。
- 院外STEMI组匹配后:551例有COVID-19 vs 2755例无COVID-19,来自370家中心;64.1%年龄51-74岁,70.3%男性。
- 院内STEMI组匹配后:252例有COVID-19 vs 756例无COVID-19,来自353家中心;58.3%年龄51-74岁,60.7%男性。
红旗征与不能漏的情况
- 院内STEMI合并COVID-19者院内死亡率高达78.5%,属极高危情况,需强化监护与救治。
- 院内STEMI合并COVID-19者接受侵入性诊断或治疗性冠状动脉操作显著少于无COVID-19者,需警惕未行侵入性操作带来的风险。
研究设计与关键结果
- 研究类型:回顾性队列研究,纳入美国509家中心Vizient临床数据库连续成人STEMI患者80449例,按COVID-19诊断可能性进行倾向性匹配,主要分析中COVID-19患者与上一日历年内无COVID-19患者比较。
- 院外STEMI组匹配后551例有COVID-19 vs 2755例无COVID-19(370家中心);院内STEMI组匹配后252例有COVID-19 vs 756例无COVID-19(353家中心)。
- 院外STEMI患者接受直接经皮冠状动脉介入治疗的可能性在COVID-19状态间无显著差异。
- 院内STEMI合并COVID-19者接受侵入性诊断或治疗性冠状动脉操作显著少于无COVID-19者。
- 院外STEMI:合并COVID-19者院内死亡率15.2% vs 无COVID-19者11.2%,绝对差4.1%(95%CI 1.1%-7.0%),P=.007。
- 院内STEMI:合并COVID-19者院内死亡率78.5% vs 无COVID-19者46.1%,绝对差32.4%(95%CI 29.0%-35.9%),P<.001。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
- 作者结论:需进一步研究以理解该关联的潜在机制。
对床旁实践的改变
- 对合并COVID-19的STEMI患者,尤其是院内STEMI者,应认识到其院内死亡风险极高(78.5% vs 46.1%),床旁需强化监护与救治。
- 院外STEMI患者接受直接经皮冠状动脉介入治疗的可能性在COVID-19状态间无显著差异,提示不应仅因COVID-19状态而放弃直接经皮冠状动脉介入治疗。
- 院内STEMI合并COVID-19者接受侵入性诊断或治疗性冠状动脉操作显著更少,临床中需注意这一差异及其与高死亡率的关联。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: There has been limited research on patients with ST-segment elevation myocardial infarction (STEMI) and COVID-19.
OBJECTIVE: To compare characteristics, treatment, and outcomes of patients with STEMI with vs without COVID-19 infection.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of consecutive adult patients admitted between January 2019 and December 2020 (end of follow-up in January 2021) with out-of-hospital or in-hospital STEMI at 509 US centers in the Vizient Clinical Database (N = 80 449).
EXPOSURES: Active COVID-19 infection present during the same encounter.
MAIN OUTCOMES AND MEASURES: The primary outcome was in-hospital mortality. Patients were propensity matched on the likelihood of COVID-19 diagnosis. In the main analysis, patients with COVID-19 were compared with those without COVID-19 during the previous calendar year.
RESULTS: The out-of-hospital STEMI group included 76 434 patients (551 with COVID-19 vs 2755 without COVID-19 after matching) from 370 centers (64.1% aged 51-74 years; 70.3% men). The in-hospital STEMI group included 4015 patients (252 with COVID-19 vs 756 without COVID-19 after matching) from 353 centers (58.3% aged 51-74 years; 60.7% men). In patients with out-of-hospital STEMI, there was no significant difference in the likelihood of undergoing primary percutaneous coronary intervention by COVID-19 status; patients with in-hospital STEMI and COVID-19 were significantly less likely to undergo invasive diagnostic or therapeutic coronary procedures than those without COVID-19. Among patients with out-of-hospital STEMI and COVID-19 vs out-of-hospital STEMI without COVID-19, the rates of in-hospital mortality were 15.2% vs 11.2% (absolute difference, 4.1% [95% CI, 1.1%-7.0%]; P = .007). Among patients with in-hospital STEMI and COVID-19 vs in-hospital STEMI without COVID-19, the rates of in-hospital mortality were 78.5% vs 46.1% (absolute difference, 32.4% [95% CI, 29.0%-35.9%]; P < .001).
CONCLUSIONS AND RELEVANCE: Among patients with out-of-hospital or in-hospital STEMI, a concomitant diagnosis of COVID-19 was significantly associated with higher rates of in-hospital mortality compared with patients without a diagnosis of COVID-19 from the past year. Further research is required to understand the potential mechanisms underlying this association.
参考来源
- Saad M, Kennedy KF, Imran H, et al. Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction. JAMA. 2021. PMID: 34714327. doi:10.1001/jama.2021.18890
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。